rp-323
Generic: 12-O-tetradecanoylphorbol-13-acetate
rp-323: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| RICH PHARMACEUTICALS, INC. (RCHA) | Preclinical |
Get deeper analysis on rp-323
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis